Danaher Corporation (DHR) Position Increased by Kidder Stephen W

Kidder Stephen W boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 1.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,191 shares of the conglomerate’s stock after buying an additional 841 shares during the period. Danaher Corporation comprises about 1.7% of Kidder Stephen W’s investment portfolio, making the stock its 24th largest position. Kidder Stephen W’s holdings in Danaher Corporation were worth $4,489,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. State of Alaska Department of Revenue increased its stake in Danaher Corporation by 41.4% in the first quarter. State of Alaska Department of Revenue now owns 17,278 shares of the conglomerate’s stock worth $1,476,000 after buying an additional 5,058 shares during the period. Motco increased its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares during the period. Douglas Lane & Associates LLC increased its stake in Danaher Corporation by 1.8% in the first quarter. Douglas Lane & Associates LLC now owns 555,791 shares of the conglomerate’s stock worth $47,537,000 after buying an additional 9,684 shares during the period. Hudson Valley Investment Advisors Inc. ADV bought a new stake in Danaher Corporation during the first quarter worth about $567,000. Finally, Diversified Trust Co increased its stake in Danaher Corporation by 1.1% in the first quarter. Diversified Trust Co now owns 4,812 shares of the conglomerate’s stock worth $412,000 after buying an additional 52 shares during the period. Institutional investors own 76.12% of the company’s stock.

Shares of Danaher Corporation (NYSE DHR) opened at 82.16 on Friday. The company’s 50-day moving average is $82.08 and its 200 day moving average is $84.16. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.01. The stock has a market capitalization of $57.08 billion, a P/E ratio of 26.22 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.90 earnings per share. On average, equities analysts forecast that Danaher Corporation will post $3.95 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://stocknewstimes.com/2017/08/27/danaher-corporation-dhr-position-increased-by-kidder-stephen-w.html.

A number of research firms have recently issued reports on DHR. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 price target on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price target on the stock in a research note on Friday, July 28th. Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Finally, Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $91.76.

In other Danaher Corporation news, insider William King sold 7,458 shares of the company’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total transaction of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Insiders have sold 27,808 shares of company stock valued at $2,296,236 in the last ninety days. Company insiders own 12.20% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply